Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-04-2017 | Review Article

The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis

Authors: Ping Duan, Yong Liu, Jiawen Li

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 4/2017

Abstract

Purpose

Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of anti-inflammatory drugs that are used in ophthalmologic surgery. These drugs do not have a steroid structure, but can inhibit surgery-induced miosis, anterior chamber inflammation, and cystoid macular edema (CME). However, the application of NSAIDs remains controversial. Therefore, we performed a meta-analysis to assess the efficacy and safety of NSAIDs for the treatment of anterior chamber inflammation after cataract surgery.

Methods

Relevant articles were identified from the PubMed, Embase, and Cochrane databases up to October 2016. The therapeutic effect of NSAIDs on anterior chamber inflammation was evaluated. The important outcomes of overall anterior chamber inflammation, freedom from ocular pain, and treatment-related/serious ocular adverse events were analyzed by using a random-effects network meta-analysis. The quality of evidence was assessed via the Grading of Recommendation Assessment, Development, and Evaluation (GRADE) approach.

Results

A total of 19 trials assessing 7,234 patients were included in our meta-analysis. Diclofenac was the most likely to improve anterior chamber inflammation after cataract surgery, followed by nepafenac, ketorolac, bromfenac, and flurbiprofen. Nepafenac was most likely to improve postoperative ocular pain relief, followed by bromfenac and ketorolac. Our analysis of treatment-related/serious ocular adverse events revealed that piroxicam was most likely to have the fewest related adverse events, but the robustness of this finding was low. Diclofenac was another near-ideal drug, followed by nepafenac, bromfenac, and ketorolac.

Conclusions

NSAIDs are effective drugs compared to placebos for the relief of anterior chamber inflammation. Furthermore, diclofenac, nepafenac, ketorolac, and bromfenac demonstrated relatively greater significant effects than those of other NSAIDs.

Tsui PH, Huang CC, Zhou Q, Shung KK (2011) Cataract measurement by estimating the ultrasonic statistical parameter using an ultrasound needle transducer: an in vitro study. Physiol Meas 32:513–522. doi:10.1088/0967-3334/32/5/002 CrossRefPubMedPubMedCentral

Isaacs R, Ram J, Apple D (2004) Cataract blindness in the developing world: is there a solution? J Agromedicine 9:207–220PubMed

Lam DS, Li EY, Chang DF, Zhang MZ, Zhan HK, Pang CP (2009) Project vision: a new and sustainable model for eliminating cataract blindness in China. Clin Exp Ophthalmol 37:427–430. doi:10.1111/j.1442-9071.2009.02084.x CrossRefPubMed

Shen W, Yang Y, Yu M, Li J, Wei T, Li X, Li J, Su X, Zhong H, Yuan Y (2013) Prevalence and outcomes of cataract surgery in adult rural Chinese populations of the Bai nationality in Dali: the Yunnan minority eye study. PLoS One 8:e60236. doi:10.1371/journal.pone.0060236 CrossRefPubMedPubMedCentral

Rofagha S, Bhisitkul RB (2011) Management of retained lens fragments in complicated cataract surgery. Curr Opin Ophthalmol 22:137–140. doi:10.1097/ICU.0b013e3283436fc5 CrossRefPubMed

Jammal HM, Khader Y, Shawer R, Al Bdour M (2012) Posterior segment causes of reduced visual acuity after phacoemulsification in eyes with cataract and obscured fundus view. Clin Ophthalmol 6:1843–1848. doi:10.2147/OPTH.S38303 CrossRefPubMedPubMedCentral

Melancia D, Abegão Pinto L, Marques-Neves C (2015) Cataract surgery and intraocular pressure. Ophthal Res 53:141–148. doi:10.1159/000377635 CrossRef

Higashide T, Sugiyama K (2008) Use of viscoelastic substance in ophthalmic surgery - focus on sodium hyaluronate. Clin Ophthalmol 2:21–30CrossRefPubMedPubMedCentral

Waterbury LD, Galindo D, Villanueva L, Nguyen C, Patel M, Borbridge L, Attar M, Schiffman RM, Hollander DA (2011) Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation. J Ocul Pharmacol Ther 27:173–178. doi:10.1089/jop.2010.0135 CrossRefPubMedPubMedCentral

10.

Ruan KH, Cervantes V, So SP (2009) Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2. Protein Eng Des Sel 22:733–740. doi:10.1093/protein/gzp058 CrossRefPubMedPubMedCentral

11.

Nichols J, Snyder RW (1998) Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol 9:40–44. doi:10.1097/00055735-199808000-00007 CrossRefPubMed

12.

Rothova A (2007) Inflammatory cystoid macular edema. Curr Opin Ophthalmol 18:487–492. doi:10.1097/ICU.0b013e3282f03d2e CrossRefPubMed

13.

Sivaprasad S, Bunce C, Wormald R (2005) Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol 89:1420–1422. doi:10.1136/bjo.2005.073817 CrossRefPubMedPubMedCentral

14.

Sivaprasad S, Bunce C, Crosby-Nwaobi R (2012) Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev CD004239. doi: 10.1002/14651858.CD004239.pub3

15.

Yilmaz T, Cordero-Coma M, Gallagher MJ (2012) Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. Eye (Lond) 26:252–258. doi:10.1038/eye.2011.296 CrossRef

16.

Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ (2015) Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology 122:2159–2168. doi:10.1016/j.ophtha.2015.05.014 CrossRefPubMed

17.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. doi:10.1371/journal.pmed.1000097 CrossRefPubMedPubMedCentral

18.

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. doi:10.1136/bmj.d5928 CrossRefPubMedPubMedCentral

19.

Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, Brozek J, Vist G, Rind D, Akl EA, Schünemann HJ (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719–725. doi:10.1016/j.jclinepi.2012.03.013 CrossRefPubMed

20.

Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C (2016) Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ 353:i1777. doi:10.1136/bmj.i1777 CrossRefPubMedPubMedCentral

21.

White IR, Barrett JK, Jackson D, Higgins JP (2012) Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 3:111–125. doi:10.1002/jrsm.1045 CrossRefPubMedPubMedCentral

22.

Li D, Wang T, Shen S, Cheng S, Yu J, Zhang Y, Zhang C, Tang H (2015) Effects of fluroquinolones in newly diagnosed, sputum-positive tuberculosis therapy: a systematic review and network meta-analysis. PLoS One 10:e0145066. doi:10.1371/journal.pone.0145066 CrossRefPubMedPubMedCentral

23.

Trinquart L, Chatellier G, Ravaud P (2012) Adjustment for reporting bias in network meta-analysis of antidepressant trials. BMC Med Res Methodol 12:150. doi:10.1186/1471-2288-12-150 CrossRefPubMedPubMedCentral

24.

Hovanesian JA, Sheppard JD, Trattler WB, Gayton JL, Malhotra RP, Schaaf DT, Ng E, Dunn SH (2015) Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: integrated results from 2 pivotal phase 3 studies. J Cataract Refract Surg 41:2060–2068. doi:10.1016/j.jcrs.2015.10.053 CrossRefPubMed

25.

Modi SS, Lehmann RP, Walters TR, Fong R, Christie WC, Roel L, Nethery D, Sager D, Tsorbatzoglou A, Philipson B, Traverso CE, Reiser H (2014) Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study. J Cataract Refract Surg 40:203–211. doi:10.1016/j.jcrs.2013.07.042 CrossRefPubMed

26.

Walters TR, Goldberg DF, Peace JH, Gow JA, Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group (2014) Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology 121:25–33. doi:10.1016/j.ophtha.2013.07.006 CrossRefPubMed

27.

Numaga J (2011) Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients. J Ophthal Inflamm Infect 1:147–155. doi:10.1007/s12348-011-0036-8 CrossRef

28.

Henderson BA, Gayton JL, Chandler SP, Gow JA, Klier SM, McNamara TR, Bromfenac Ophthalmic Solution (Bromday) Once Daily Study Group (2011) Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain. Ophthalmology 118:2120–2127. doi:10.1016/j.ophtha.2011.04.035 CrossRefPubMed

29.

Donnenfeld ED, Nichamin LD, Hardten DR, Raizman MB, Trattler W, Rajpal RK, Alpern LM, Felix C, Bradford RR, Villanueva L, Hollander DA, Schiffman RM (2011) Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery. Am J Ophthalmol 151:420.e1–426.e1. doi:10.1016/j.ajo.2010.09.003 CrossRef

30.

Maxwell WA, Reiser HJ, Stewart RH, Cavanagh HD, Walters TR, Sager DP, Meuse PA (2008) Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. J Ocul Pharmacol Ther 24:593–599. doi:10.1089/jop.2008.0023 CrossRefPubMed

31.

Stewart RH, Grillone LR, Shiffman ML, Donnenfeld ED, Gow JA, Bromfenac Ophthalmic Solution 0.09% Study Group (2007) The systemic safety of bromfenac ophthalmic solution 0.09%. J Ocul Pharmacol Ther 23:601–612. doi:10.1089/jop.2007.0040 CrossRefPubMed

32.

Lane SS, Modi SS, Lehmann RP, Holland EJ (2007) Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg 33:53–58. doi:10.1016/j.jcrs.2006.08.043 CrossRefPubMed

33.

Scuderi B, Driussi GB, Chizzolini M, Salvetat ML, Beltrame G (2003) Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery. Eur J Ophthalmol 13:536–540PubMed

34.

Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A (2001) Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108:331–337. doi:10.1016/S0161-6420(00)00543-1 CrossRefPubMed

35.

Stewart R, Grosserode R, Cheetham JK, Rosenthal A (1999) Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 21:723–732. doi:10.1016/S0149-2918(00)88323-X CrossRefPubMed

36.

Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A (1999) Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 127:253–259. doi:10.1016/S0002-9394(98)00413-9 CrossRefPubMed

37.

Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA (1998) Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 105:1775–1779. doi:10.1016/S0161-6420(98)99053-4 CrossRefPubMed

38.

Koçak I, Yalvaç IS, Koçak A, Nurözler A, Unlü N, Kasim R, Duman S (1998) Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction. Acta Ophthalmol Scand 76:343–345. doi:10.1034/j.1600-0420.1998.760318.x CrossRefPubMed

39.

Diestelhorst M, Schmidl B, Konen W, Mester U, Raj PS (1996) Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation. J Cataract Refract Surg 22(Suppl 1):788–793. doi:10.1016/S0886-3350(96)80163-5 CrossRefPubMed

40.

Blaydes JE Jr, Kelley EP, Walt JG, DeGryse RE, Harper DG, Novack GD (1993) Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsification. J Cataract Refract Surg 19:481–487. doi:10.1016/S0886-3350(13)80611-6 CrossRefPubMed

41.

Kraff MC, Martin RG, Neumann AC, Weinstein AJ (1994) Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg 20:138–144. doi:10.1016/S0886-3350(13)80153-8 CrossRefPubMed

42.

Sabiston D, Tessler H, Sumers K, Osterle C, Cheetham JK, Duzman E, DeGryse R (1987) Reduction of inflammation following cataract surgery by the nonsteroidal anti-inflammatory drug, flurbiprofen. Ophthal Surg 18:873–877

43.

Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN (2000) The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents 14:249–251. doi:10.1016/S0924-8579(99)00159-4 CrossRefPubMed

44.

Serhan CN, Chiang N (2002) Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. ScientificWorldJournal 2:169–204. doi:10.1100/tsw.2002.81 CrossRefPubMed

45.

Zhang JY, Feng YF, Cai JQ (2013) Phacoemulsification versus manual small-incision cataract surgery for age-related cataract: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol 41:379–386. doi:10.1111/j.1442-9071.2012.02868.x CrossRefPubMed

46.

Wielders LH, Lambermont VA, Schouten JS, van den Biggelaar FJ, Worthy G, Simons RW, Winkens B, Nuijts RM (2015) Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 160:968.e33–981.e33. doi:10.1016/j.ajo.2015.07.032 CrossRef

47.

van Endt JJ, Veraart HG, Kramer R, Janssen AG, Sunder Raj P (1997) A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery. Eur J Ophthalmol 7:144–148PubMed

48.

Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group (2008) A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 146:554–560. doi:10.1016/j.ajo.2008.04.036 CrossRefPubMed

Title: The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis
Authors: Ping Duan
Yong Liu
Jiawen Li
Publication date: 01-04-2017
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 4/2017
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-017-3599-8

At a glance: The STEP trials

Springer Medicine

The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2017

Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity

High-frequency aflibercept injections in persistent neovascular age-related macular degeneration

Microperimetry and multimodal retinal imaging, Edoardo Midena (ed). Part of the series "Essentials in Ophthalmology", Series editor Singh AD. (2014) ISBN 978-3642-4029-99 Springer

The effect of orbital decompression surgery on interpupillary distance and angle kappa in patients with thyroid-associated orbitopathy

Two different techniques for frontalis suspension using Gore-Tex to treat severe congenital ptosis

Letter to the editor. “Comparison of specular microscopy and ultrasound pachymetry before and after cataract surgery”